Brown Brothers Harriman & Co’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-250
Closed -$20K 946
2016
Q4
$20K Hold
250
﹤0.01% 629
2016
Q3
$20K Hold
250
﹤0.01% 549
2016
Q2
$20K Hold
250
﹤0.01% 558
2016
Q1
$14K Hold
250
﹤0.01% 547
2015
Q4
$15K Hold
250
﹤0.01% 595
2015
Q3
$16K Sell
250
-259
-51% -$18.5K ﹤0.01% 641
2015
Q2
$37K Hold
509
﹤0.01% 533
2015
Q1
$33K Hold
509
﹤0.01% 549
2014
Q4
$33K Hold
509
﹤0.01% 575
2014
Q3
$31K Sell
509
-24
-5% -$1.57K ﹤0.01% 585
2014
Q2
$37K Hold
533
﹤0.01% 549
2014
Q1
$35K Sell
533
-250
-32% -$16.3K ﹤0.01% 545
2013
Q4
$49K Sell
783
-17
-2% -$984 ﹤0.01% 469
2013
Q3
$43K Sell
800
-7,800
-91% -$402K ﹤0.01% 487
2013
Q2
$392K Buy
+8,600
New +$373K ﹤0.01% 308

Other funds holding STJ

Brown Brothers Harriman & Co's STJ Position: Q1 2017 in Review

Brown Brothers Harriman & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 250 shares — an estimated $20K sold.

Brown Brothers Harriman & Co first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $392K in Q2 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Brown Brothers Harriman & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 250 St Jude Medical shares in Q1 2017, an estimated $20K.
  • Brown Brothers Harriman & Co first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Brown Brothers Harriman & Co's St Jude Medical position peaked at $392K in Q2 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2017, filed 12 May 2017.